Taguchi M, Sampath D, Koga T, Castro M, Look D C, Nakajima S, Holtzman M J
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Exp Med. 1998 Jun 15;187(12):1927-40. doi: 10.1084/jem.187.12.1927.
Immune cell migration into and through mucosal barrier sites in general and airway sites in particular is a critical feature of immune and inflammatory responses, but the determinants of transepithelial (unlike transendothelial) immune cell traffic are poorly defined. Accordingly, we used primary culture airway epithelial cells and peripheral blood mononuclear cells to develop a cell monolayer system that allows for apical-to-basal and basal-to-apical T cell transmigration that can be monitored with quantitative immunofluorescence flow cytometry. In this system, T cell adhesion and subsequent transmigration were blocked in both directions by monoclonal antibodies (mAbs) against lymphocyte function-associated antigen 1 (LFA-1) or intercellular adhesion molecule 1 (ICAM-1) (induced by interferon gamma [IFN-gamma] treatment of epithelial cells). The total number of adherent plus transmigrated T cells was also similar in both directions, and this pattern fit with uniform presentation of ICAM-1 along the apical and basolateral cell surfaces. However, the relative number of transmigrated to adherent T cells (i.e., the efficiency of transmigration) was increased in the basal-to-apical relative to the apical-to-basal direction, so an additional mechanism was needed to mediate directional movement towards the apical surface. Screening for epithelial-derived beta-chemokines indicated that IFN-gamma treatment caused selective expression of RANTES (regulated upon activation, normal T cell expressed and secreted), and the functional significance of this finding was demonstrated by inhibition of epithelial-T cell adhesion and transepithelial migration by anti-RANTES mAbs. In addition, we found that epithelial (but not endothelial) cells preferentially secreted RANTES through the apical cell surface thereby establishing a chemical gradient for chemotaxis across the epithelium to a site where they may be retained by high levels of RANTES and apical ICAM-1. These patterns for epithelial presentation of ICAM-1 and secretion of RANTES appear preserved in airway epithelial tissue studied either ex vivo with expression induced by IFN-gamma treatment or in vivo with endogenous expression induced by inflammatory disease (i.e., asthma). Taken together, the results define how the patterns for uniform presentation of ICAM-1 along the cell surface and specific apical sorting of RANTES may serve to mediate the level and directionality of T cell traffic through epithelium (distinct from endothelium) and provide a basis for how this process is precisely coordinated to route immune cells to the mucosal surface and maintain them there under normal and stimulated conditions.
一般而言,免疫细胞迁移至黏膜屏障部位并穿过该部位,尤其是气道部位,这是免疫和炎症反应的一个关键特征,但跨上皮(与跨内皮不同)免疫细胞运输的决定因素仍不清楚。因此,我们使用原代培养的气道上皮细胞和外周血单核细胞建立了一个细胞单层系统,该系统允许T细胞从顶端到基底以及从基底到顶端的迁移,并且可以通过定量免疫荧光流式细胞术进行监测。在这个系统中,针对淋巴细胞功能相关抗原1(LFA-1)或细胞间黏附分子1(ICAM-1)的单克隆抗体(mAb)在两个方向上均阻断了T细胞的黏附及随后的迁移(上皮细胞经干扰素γ [IFN-γ] 处理后诱导产生ICAM-1)。黏附加迁移的T细胞总数在两个方向上也相似,并且这种模式与ICAM-1沿顶端和基底外侧细胞表面的均匀呈现相符合。然而,相对于从顶端到基底的方向,从基底到顶端迁移的T细胞与黏附的T细胞的相对数量(即迁移效率)增加,因此需要一种额外的机制来介导朝向顶端表面的定向运动。对上皮来源的β趋化因子进行筛选表明,IFN-γ处理导致调节激活正常T细胞表达和分泌因子(RANTES)的选择性表达,抗RANTES mAb抑制上皮-T细胞黏附和跨上皮迁移证明了这一发现的功能意义。此外,我们发现上皮细胞(而非内皮细胞)优先通过顶端细胞表面分泌RANTES,从而在上皮细胞间建立一个趋化作用的化学梯度,使其到达一个可能被高水平RANTES和顶端ICAM-1滞留的部位。ICAM-1的上皮呈现模式和RANTES的分泌模式在体外经IFN-γ处理诱导表达或在体内经炎症性疾病(即哮喘)诱导内源性表达所研究的气道上皮组织中似乎得以保留。综上所述,这些结果确定了ICAM-1沿细胞表面均匀呈现的模式以及RANTES的特定顶端分选模式如何介导T细胞通过上皮(与内皮不同)的运输水平和方向性,并为该过程如何精确协调以将免疫细胞引导至黏膜表面并在正常和刺激条件下将它们维持在那里提供了基础。